Prospera Financial Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,083
| Closed | -$206K | – | 1168 |
|
|
2024
Q3 | $206K | Sell |
3,083
-13,673
| -82% | -$914K | 0.01% | 1071 |
|
|
2024
Q2 | $1.99M | Buy |
16,756
+13,093
| +357% | +$1.55M | 0.06% | 338 |
|
|
2024
Q1 | $390K | Buy |
3,663
+28
| +0.8% | +$2.98K | 0.01% | 796 |
|
|
2023
Q4 | $362K | Sell |
3,635
-829
| -19% | -$82.4K | 0.01% | 772 |
|
|
2023
Q3 | $461K | Sell |
4,464
-777
| -15% | -$80.3K | 0.02% | 643 |
|
|
2023
Q2 | $637K | Sell |
5,241
-863
| -14% | -$105K | 0.02% | 543 |
|
|
2023
Q1 | $937K | Sell |
6,104
-7,509
| -55% | -$1.15M | 0.04% | 452 |
|
|
2022
Q4 | $2.45M | Buy |
13,613
+8,214
| +152% | +$1.48M | 0.12% | 198 |
|
|
2022
Q3 | $639K | Buy |
5,399
+3,113
| +136% | +$368K | 0.03% | 464 |
|
|
2022
Q2 | $327K | Sell |
2,286
-523
| -19% | -$74.8K | 0.02% | 610 |
|
|
2022
Q1 | $484K | Buy |
2,809
+106
| +4% | +$18.3K | 0.02% | 606 |
|
|
2021
Q4 | $687K | Sell |
2,703
-3,230
| -54% | -$821K | 0.03% | 487 |
|
|
2021
Q3 | $2.28M | Buy |
5,933
+384
| +7% | +$148K | 0.11% | 218 |
|
|
2021
Q2 | $1.3M | Buy |
5,549
+1,426
| +35% | +$335K | 0.07% | 327 |
|
|
2021
Q1 | $539K | Buy |
4,123
+145
| +4% | +$19K | 0.03% | 471 |
|
|
2020
Q4 | $415K | Buy |
3,978
+3,803
| +2,173% | +$397K | 0.03% | 452 |
|
|
2020
Q3 | $12K | Buy |
+175
| New | +$12K | ﹤0.01% | 1063 |
|